Octant, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP) (NCT07408232) | Octant, Inc. | 2026-03-10 |
Track Octant, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.